Comments to the SAMR on the Anti-monopoly Guide for the Active Pharmaceutical Ingredients Field

2020-10-30 | Beijing, Shanghai

As the situation of price monopoly caused by the alliance of API suppliers is worsening, it is necessary to enact the Antitrust Guidelines for APIs. European pharmaceutical manufacturers very welcome the Chinese government to introduce regulations to crack down the price monopoly of API.